XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Total
Beginning balance at Jun. 28, 2020 $ 225 $ 33,531 $ (8,716) $ (24,537) $ 503
Beginning balance (in shares) at Jun. 28, 2020 22,550,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity issue costs - ATM Offering $ 0 (3) 0 $ 0 (3)
Net income 0 0 76 0 76
Ending balance at Sep. 27, 2020 $ 225 33,528 (8,640) $ (24,537) 576
Ending balance (in shares) at Sep. 27, 2020 22,550,000     (7,085,000)  
Beginning balance at Jun. 28, 2020 $ 225 33,531 (8,716) $ (24,537) 503
Beginning balance (in shares) at Jun. 28, 2020 22,550,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income         594
Ending balance at Mar. 28, 2021 $ 251 37,174 (8,122) $ (24,537) 4,766
Ending balance (in shares) at Mar. 28, 2021 25,090,000     (7,085,000)  
Beginning balance at Sep. 27, 2020 $ 225 33,528 (8,640) $ (24,537) 576
Beginning balance (in shares) at Sep. 27, 2020 22,550,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Common Stock $ 26 3,735 0 $ 0 3,761
Issuance of Common Stock (in shares) 2,540,000        
Equity issue costs - ATM Offering $ 0 (127) 0 0 (127)
Net income 0 0 102 0 102
Ending balance at Dec. 27, 2020 $ 251 37,136 (8,538) $ (24,537) 4,312
Ending balance (in shares) at Dec. 27, 2020 25,090,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity issue costs - ATM Offering $ 0 (1) 0 $ 0 (1)
Stock compensation expense 0 39 0 0 39
Net income 0 0 416 0 416
Ending balance at Mar. 28, 2021 $ 251 37,174 (8,122) $ (24,537) 4,766
Ending balance (in shares) at Mar. 28, 2021 25,090,000     (7,085,000)  
Beginning balance at Jun. 27, 2021 $ 251 37,215 (7,196) $ (24,537) $ 5,733
Beginning balance (in shares) at Jun. 27, 2021 25,090,000     (7,085,000) 18,004,904
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock compensation expense $ 0 42 0 $ 0 $ 42
Net income 0 0 285 0 285
Ending balance at Sep. 26, 2021 $ 251 37,257 (6,911) $ (24,537) 6,060
Ending balance (in shares) at Sep. 26, 2021 25,090,000     (7,085,000)  
Beginning balance at Jun. 27, 2021 $ 251 37,215 (7,196) $ (24,537) $ 5,733
Beginning balance (in shares) at Jun. 27, 2021 25,090,000     (7,085,000) 18,004,904
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income         $ 1,235
Ending balance at Mar. 27, 2022 $ 251 37,342 (5,961) $ (24,537) $ 7,095
Ending balance (in shares) at Mar. 27, 2022 25,090,000     (7,085,000) 18,004,904
Beginning balance at Sep. 26, 2021 $ 251 37,257 (6,911) $ (24,537) $ 6,060
Beginning balance (in shares) at Sep. 26, 2021 25,090,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock compensation expense $ 0 43 0 $ 0 43
Net income 0 0 457 0 457
Ending balance at Dec. 26, 2021 $ 251 37,300 (6,454) $ (24,537) 6,560
Ending balance (in shares) at Dec. 26, 2021 25,090,000     (7,085,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock compensation expense $ 0 42 0 $ 0 42
Net income 0 0 493 0 493
Ending balance at Mar. 27, 2022 $ 251 $ 37,342 $ (5,961) $ (24,537) $ 7,095
Ending balance (in shares) at Mar. 27, 2022 25,090,000     (7,085,000) 18,004,904